Stock screenerAll disclosures →
EDGAR →
RGEN
Conviction 89HealthcareScan · Thu, Sep 24, 2026Bullish engulfing
Repligen Corp (RGEN) closed at $190.57 (+3.27%) on Sep 24, 2026. Its latest daily candle is a bullish engulfing. Price is above its 50-day and above its 200-day moving average. RSI(14) 69, RS Rating 94, at a 52-week high, +16.0% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).
RGEN$190.57+3.27%
ResistanceSupportVol 14Insider sellCongress buyCongress sellVol MA14 994.17K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Price190.57
Change+3.27%
Gap-0.11%
Rel volume1.84×
Avg volume991.49K
Avg $ vol173.9M
SMA 20174.81
SMA 50164.19
SMA 200142.68
Price vs 50+16.06%
Price vs 200+33.56%
MA stackbullish
50/200 cross—
Supertrendup · 167.81
RSI (14)69
MACD hist1.28
MACD crossbull · 3d
Stoch %K / %D94 / 91
ADX (14)38
+DI / −DI31 / 10
RSI divergence—
MACD divergence—
ATR %3.58%
ADR %3.84%
52w high190.57
52w low102.87
From 52w high+0.00%
Above 52w low+85.25%
New 52w highYes
SqueezeOff
Bollinger width17.08%
%B1.03
Donchian pos93.82%
Donchian high192.51
Donchian low161.14
AVWAP (52w high)188.94
vs AVWAP high+0.86%
AVWAP (52w low)145.89
vs AVWAP low+30.62%
OBV trendFlat
Chaikin MF (20)0.07
Today vs 20d1.84×
Avg vol (14d)994.17K
Avg vol (20d)991.49K
Avg $ vol (20d)173.9M
Market cap10.75B
RS Rating94 / 99
RS 3m (vs SPY)+26.73%
RS 6m (vs SPY)+49.88%
RS line new highYes
Trend template6/8
Technical rank94.6
1 week+6.95%
1 month+4.89%
3 months+31.22%
6 months+66.70%
1 year+53.75%
YTD+15.95%
P/E219.96
P/B5.09
P/S76.15
P/FCF114.54
EPS0.8600
Div yield—
ROE2.31%
ROA1.66%
Debt/Eq0.26
Current9.05
EV/EBITDA79.90
Gross margin42.83%
Net margin34.62%
Rev growth35.10%
EPS growth291.64%
Price target181.67
Target upside-4.67%
Analyst ratingBuy
Institutional127.11%
Ent. value10.7B
Revenue44.83M
Net income5.01M
Gross profit—
Free cash flow93.9M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out56.41M
Employees2K
ListedTue, Apr 29, 1986
Free float55.93M
Float %99.2%
Short interest6.61M
Days to cover6.7d
Short volume67.2%
Squeeze score79 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.54 vs $0.45
Last surprise+20.0% beat
Setup gradeA+
Conviction89 / 100
Pattern quality—
Tech rank94.6 / 100
Group rank59 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBullish engulfing
Financials as of Tue, Jun 30, 2026 · quarterly.
Signal lifecycle
How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.
- Setting upAug 311 scan
- Broke outSep 21 – Sep 233 scans
Recent news
- (RGEN) Movement as an Input in Quant Signal SetsStock Traders Daily · Wed, Sep 23, 2026
- Repligen Corp (RGEN) CEO Olivier Loeillot Sells 5,426 SharesGuruFocus · Wed, Sep 23, 2026
- RGEN261016C00155000 Interactive Stock Chart | RGEN Oct 2026 155.000 call StockYahoo Finance · Wed, Sep 23, 2026
- Repligen Corp (RGEN) Stock Up 3.3% but GF Value Says Overvalued -- GF Score: 87/100GuruFocus · Tue, Sep 22, 2026
- Repligen (RGEN) CEO sells 5,426 shares under planStock Titan · Tue, Sep 22, 2026
- Repligen (NASDAQ: RGEN) insider plans new stock sale after two recent tradesStock Titan · Mon, Sep 21, 2026
Congress activity
Disclosed STOCK Act trades in RGEN · 6 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Lisa McClain house · MI · traded 2025-10-30 | Sell | $1K–$15K | 2025-10-30 | 2025-11-01 | |
Lisa McClain house · MI · traded 2025-10-31 | Sell | $1K–$15K | 2025-10-31 | 2025-11-01 | |
Lisa McClain house · R · MI · traded 2025-06-17 | Sell | $1K–$15K | 2025-06-17 | 2025-08-13 | |
Lisa McClain house · R · MI · traded 2025-07-22 | Buy | $1K–$15K | 2025-07-22 | 2025-08-13 | |
Lisa McClain house · R · MI · traded 2025-06-11 | Buy | $1K–$15K | 2025-06-11 | 2025-08-13 | |
 Jefferson Shreve house · R · IN · traded 2025-04-07 | Sell | $15K–$50K | 2025-04-07 | 2025-05-08 |
Insider activity
SEC Form 4 transactions in RGEN · open-market 2 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Hughes Violetta CHIEF ACCOUNTING OFFICER · Common Stock · 2026-09-01 | Tax | 277 | $47K | 2026-09-01 | 2026-09-02 |
Hughes Violetta CHIEF ACCOUNTING OFFICER · Common Stock · 2026-03-05 | Grant | 2.47K | — | 2026-03-05 | 2026-09-02 |
Loeillot Olivier Chief Executive Officer · Common Stock · 2026-08-20 | Exercise | 5.43K | $769K | 2026-08-20 | 2026-08-21 |
Loeillot Olivier Chief Executive Officer · Common Stock · 2026-08-20 | Sell | 5.43K | $977K | 2026-08-20 | 2026-08-21 |
Loeillot Olivier Chief Executive Officer · Stock Option (Right to Buy) · 2026-08-20 | Exercise | 5.43K | — | 2026-08-20 | 2026-08-21 |
Garland Jason K CFO · Common Stock · 2026-07-16 | Sell | 530 | $80K | 2026-07-16 | 2026-07-17 |
EGLINTON MANNER CARRIE Director · Common Stock · 2026-05-14 | Grant | 995 | $0 | 2026-05-14 | 2026-05-18 |
BARTHELEMY NICOLAS Director · Common Stock · 2026-05-14 | Grant | 995 | $0 | 2026-05-14 | 2026-05-18 |
Pax Margaret Director · Stock Option (Right to Buy) · 2026-05-14 | Grant | 2.24K | $0 | 2026-05-14 | 2026-05-18 |
BARTHELEMY NICOLAS Director · Stock Option (Right to Buy) · 2026-05-14 | Grant | 2.24K | $0 | 2026-05-14 | 2026-05-18 |
SEC filings
EDGAR filings in RGEN · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.